Parasite | Eso | Sto | Cancer | ESD
001 | 101 | 201 | 301 | 401 | 501 | 601 | 701 | 801 | 901 | 1000
Á¶Á÷°Ë»ç´Â papillary adenocarcinoma¿´½À´Ï´Ù. ¾î¶² Ä¡·á¸¦ ¼±ÅÃÇϽðڽÀ´Ï±î?
¾Æ·¡·Î
¾Æ·¡·Î
¾Æ·¡·Î
¾Æ·¡·Î
¾Æ·¡·Î
Papillary adenocarcinoma´Â tubular adenocarcinoma¿¡ ºñÇÏ¿© ¿¹ÈÄ°¡ ´Ù¼Ò ³ª»Þ´Ï´Ù. °£ÀüÀÌ¿Í ¿¬°üµÈ venous invasion°¡ ÈçÇϱ⠶§¹®À̶ó°íµµ ÇÕ´Ï´Ù.
Papillary adenocarcinomaµµ EMR/ESD¸¦ ÇÏ´Â °ÍÀÌ ÁÁÀ»Áö ±Ã±ÝÇÏÁö ¾ÊÀ» ¼ö ¾ø½À´Ï´Ù. Á¦°¡ º´¸®°ú¿¡ ¹®ÀÇÇÏ¿´À» ¶§¿¡´Â ÀϹÝÀûÀ¸·Î Á¶±âÀ§¾Ï¿¡¼´Â tubular adenocarcinoma¿Í ¶È°°ÀÌ º¸¸é µÇ°í ´ÜÁö SM invasion ÀÌ ÀÖ´Â °æ¿ì´Â venous invasion chance°¡ ³ô¾ÆÁú ¼ö ÀÖ´Ù´Â ´äº¯À» µé¾ú½À´Ï´Ù.
Çö½ÇÀûÀ¸·Î Á¶±âÀ§¾ÏÀÇ EMR/ESDÀÇ ÀûÀÀÁõÀ» Á¤ÇÏ´Â ¹®Á¦¿Í EMR/ESD ÈÄ ¿ÏÀüÀýÁ¦ ¿©ºÎ¸¦ ÆÇÁ¤ÇÔ¿¡ ÀÖ¾î¼ papillary adenocarcinoma¸¦ tubular adenocarcinoma¿Í µ¿ÀÏÇÏ°Ô °£ÁÖÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àü·«¿¡ ´ëÇÑ ¿©·¯ ÀÇ°ßÀÌ ÀÖÀ» ¼ö Àִµ¥, ÇâÈÄ Áß¿äÇÑ ¿¬±¸ topicÀ̶ó°í »ý°¢ÇÕ´Ï´Ù. °ü·Ã reference (Yasuda et al. Gastric Cancer 2000;3:33-38)¸¦ Çϳª ¼Ò°³ÇÕ´Ï´Ù.
Results. PGC was characteristically found in patients over 65 years of age (68%), was located in the upper one-third of the stomach (37%), was of grossly ocalized type (85%), was negative for serosal invasion (86%), and was associated with liver metastasis (14%). The overall 5-year survival rate for patients with PGC was significantly lower than the rate for those with NGC (63% vs 76%) (P < 0.05). Although the 5-year survival rate for each stage of PGC and NGC did not differ significantly, the death of PGC patients was more frequently associated with liver metastasis (62%) than with peritoneal dissemination (5%). Independent prognostic factors of PGC were liver metastasis, serosal invasion, and lymph node metastasis. Conclusion. These results suggest that PGC is characterized by advanced patient age, proximal tumor location, grossly localized type, negative serosal invasion, and frequent liver metastasis. A poor prognosis for patients with PGC is associated with the presence or recurrence of liver metastasis.
2014. 5. 11. ÀÌÁØÇà